Skip to main content
. 2020 May 19;88:11–16. doi: 10.1016/j.bbi.2020.05.037

Table 2.

Demographic and clinical data of the patients distributed according to the time of the anamnestic interview.

Demographic and Clinical Data Group 1
1st-2th Day
(n = 33)
Group 2
3th-7th Day
(n = 31)
Group 3
>7th Day
(n = 39)
p Value
Age (Mean ± SD) 53 ± 15.65 55 ± 12.44 58 ± 16.64 ns
Sex (M, F) 15, 18 15, 16 29, 10 0.01
1vs3 0.01
2vs3 0.02
Temperature (Mean ± SD) 36 ± 0.42 36 ± 0.41 36 ± 0.4 ns

Inflammatory serum markers

WBC (x109/L) (Mean ± SD) 7.21 ± 4.59 6.1 ± 2.34 10.47 ± 7.65 0.0057
1 vs 3 0.028
2 vs 3 0.0062
Neutrophil, count (Mean ± SD) 5.35 ± 4.59 4.28 ± 2.64 7.03 ± 6.33 ns
Lymphocyte, count (Mean ± SD) 1.25 ± 0.84 1.29 ± 0.62 2.88 ± 6.01 ns
Neutrophil, %WB (Mean ± SD) 0.7 ± 0.26 0.66 ± 0.14 0.64 ± 0.22 ns
Lymphocyte, %WB (Mean ± SD) 0.2 ± 0.14 0.24 ± 0.12 0.26 ± 0.18 ns
CRP (Mean ± SD) 26.69 ± 43.83 36.93 ± 45.14 6.47 ± 12.13 0.0008
1 vs 3 0.009
2 vs 3 0.0011

sNS

0n (%) 2 (6.06) 3 (9.68) 4 (10.26) ns
1–2n (%) 7 (21.21) 9 (29.03) 10 (25.64) ns
≥ 3n (%) 24 (72.72) 19 (61.29) 25 (64.10) ns
sNS Distribution
Any n (%) 30 (90.9) 24 (77.42) 37 (94.87) 0.04
1vs2 0.04
2vs3 0.04
Hyposmia n (%) 15 (45.45) 11 (35.48) 15 (38.46) ns
Dysgeusia n (%) 16 (48.48) 12 (38.7) 20 (51.28) ns
Auditory Dysfunction n (%) 0 (0) 1 (3.22) 1 (2.56) ns
Headache n (%) 16 (48.48) 14 (45.16) 11 (28.2) ns
Confusion n (%) 12 (36.36) 5 (16.12) 8 (20.51) ns
Dizziness n (%) 9 (27.27) 7 (22.58) 11 (28.2) ns
Numbness/Pareshesia n (%) 4 (12.12) 2 (6.45) 0 (0) ns
Fatigue n (%) 15 (45.45) 7 (22.58) 12 (30.77) ns
Daytime Sleepiness n (%) 15 (45.45) 14 (45.16) 7 (17.95) 0.01
1vs3; 0.037
2vs3; 0.044
Sleep Impairment n (%) 12 (36.36) 12 (38.7) 27 (69.23) 0.03
1vs3 0.042
2vs3 0.044
Muscle Ache n (%) 13 (39.39) 11 (35.48) 2 (5.13) 0.004
1vs3 0.02
2vs3 0.008
Depression n (%) 15 (45.45) 7 (22.58) 17 (43.59) ns
Anxiety n (%) 13 (39.39) 7 (22.58) 14 (35.9) ns

List of abbreviations: n, Number of patients; M, Male patients; F, Female patients; SD, Standard Deviation; sNS, Subjective Neurological Symptoms; WBC, white blood cells; CRP, C-reactive protein; ns, Not Significant.